EIK1001: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
5
Conditions studied
15
US states with sites
24
Countries
Phase breakdown
Phase 2 2
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Advanced Melanoma | 1 |
| Lung cancer | 1 |
| Melanoma | 1 |
| Non Small Cell Lung Cancer (Squamous or Non Squamous) | 1 |
| Stage 4 NSCLC | 1 |
Recruiting trials involving EIK1001
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
- Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Common questions
How many recruiting trials involve EIK1001?
2 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.